Effectiveness of non-pharmaceutical interventions to contain COVID-19: a case study of the 2020 spring pandemic wave in New York City

Author:

Yang Wan1,Shaff Jaimie2,Shaman Jeffrey3

Affiliation:

1. Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY 10032, USA

2. New York City Department of Health and Mental Hygiene, New York, NY, USA

3. Department of Environmental Health Sciences, Mailman School of Public Health, Columbia University, New York, NY, USA

Abstract

As COVID-19 continues to pose significant public health threats, quantifying the effectiveness of different public health interventions is crucial to inform intervention strategies. Using detailed epidemiological and mobility data available for New York City and comprehensive modelling accounting for under-detection, we reconstruct the COVID-19 transmission dynamics therein during the 2020 spring pandemic wave and estimate the effectiveness of two major non-pharmaceutical interventions—lockdown-like measures that reduce contact rates and universal masking. Lockdown-like measures were associated with greater than 50% transmission reduction for all age groups. Universal masking was associated with an approximately 7% transmission reduction overall and up to 20% reduction for 65+ year olds during the first month of implementation. This result suggests that face covering can substantially reduce transmission when lockdown-like measures are lifted but by itself may be insufficient to control SARS-CoV-2 transmission. Overall, findings support the need to implement multiple interventions simultaneously to effectively mitigate COVID-19 spread before the majority of population can be protected through mass-vaccination.

Funder

New York City Department of Health and Mental Hygiene

National Science Foundation

National Institute of Allergy and Infectious Diseases

Publisher

The Royal Society

Subject

Biomedical Engineering,Biochemistry,Biomaterials,Bioengineering,Biophysics,Biotechnology

Reference48 articles.

1. World Health Organization. 2020 Coronavirus disease (COVID-2019) situation reports. 10/5/2020 2020. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports/ (accessed 6 October 2020).

2. US Food and Drug Administration. 2020 FDA Takes Additional Action in Fight Against COVID-19 By Issuing Emergency Use Authorization for Second COVID-19 Vaccine. https://www.fda.gov/news-events/press-announcements/fda-takes-additional-action-fight-against-covid-19-issuing-emergency-use-authorization-second-covid (accessed 23 December 2020).

3. Pharmacy Times. 2020 Pfizer BioNTech Granted Authorization for COVID-19 Vaccine in the European Union. https://www.pharmacytimes.com/news/pfizer-biontech-granted-authorization-for-covid-19-vaccine-in-the-european-union (accessed 23 December 2020).

4. Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2)

5. The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3